TrialCancer2017

Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single-center, open-label, phase 2 study.

Pat Gulhati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.